Amicus Therapeutics
3675 Market Street,
Philadelphia, 19104, PA,
United States
Philadelphia, 19104, PA,
United States
1 215-921-7600
Life Sciences
Amicus Therapeutics Technographics
Amicus Therapeutics Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Amicus Therapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 500 Amicus Therapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Amicus Therapeutics has purchased the following applications: Sterling Background Check for BackGround Screening in 2018, Veeva CRM Events Management for Event Management in 2018, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Amicus Therapeutics is running and its propensity to invest more and deepen its relationship with Sterling Talent Solutions , Oracle , Veeva Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Amicus Therapeutics revenues, which have grown to $306.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Amicus Therapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Amicus Therapeutics Tech Stack and Enterprise Applications
Amicus Therapeutics HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Sterling Talent Solutions | Legacy | Sterling Background Check | BackGround Screening | HCM | n/a | 2018 | 2018 |
In 2018, Amicus Therapeutics implemented Sterling Background Check as part of its BackGround Screening to centralize candidate screening and onboarding workflows. The deployment was executed within Human Resources to manage new hire data administration, background screening orchestration, I-9 verification and offer letter gating, with operational oversight tied to the SVP Human Resources.
Sterling Background Check was configured to operate alongside Taleo ATS for candidate initiation and case management, reflecting the explicit use of Taleo ATS paired with Sterling Talent Solutions for onboarding and background processes. Workflows were established to trigger background checks from Taleo and to coordinate I-9 document verification during New Hire Orientation, while new hire record maintenance and downstream HR administration aligned with ADP HRIS, HealthEquity HSA account setup and COBRA processing.
The implementation included management of the VPAssure to Sterling Talent Solutions migration and operational integrations with Taleo ATS and ADP HRIS. Scope covered HR functions including onboarding, background screening, coordination with payroll for 401K and Morgan Stanley stock account setup, and centralized vendor contract management involving Legal and Contracts stakeholders.
Governance and process work included drafting New Hire Onboarding procedures, administering the background check lifecycle via Sterling Background Check and integrating those checks into orientation and onboarding workflows. Day to day operations were handled by HR staff who processed employee data changes, terminations and facilitated background screening as part of standard hiring governance.
|
|
|
|
|
Recruiting | HCM |
|
2018 | 2018 |
|
|
|
|
|
Recruiting, Applicant Tracking System | HCM |
|
2018 | 2018 |
|
Amicus Therapeutics Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Veeva Systems | Legacy | Veeva CRM Events Management | Event Management | Collaboration | n/a | 2018 | 2018 |
In 2018, Amicus Therapeutics implemented Veeva CRM Events Management to centralize planning and execution of corporate and scientific meetings. The deployment focused on Event Management use cases to standardize event intake, approval workflows, and compliance controls across commercial and medical affairs functions.
The Veeva CRM Events Management implementation emphasized core event management capabilities including agenda and session scheduling, speaker and faculty management, attendee registration and tracking, and automated event documentation for compliance and auditability. Governance included standardized approval gates and role based workflows to coordinate medical, legal, and commercial reviews, and the application name Veeva CRM Events Management is cataloged as the primary Event Management tool supporting Amicus Therapeutics. Amicus is also listed as a participating company at the 2019 Veeva R&D Summit, an industry event that drew life sciences professionals and vendor peers.
|
Amicus Therapeutics Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Docusign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Amicus Therapeutics deployed DocuSign eSignature as a Digital Signing capability on its public website. The implementation embeds DocuSign eSignature signing flows into web pages to capture electronic signatures for documents presented through the site, creating a web‑facing signature channel aligned with the Digital Signing category.
The configuration uses standard DocuSign eSignature functional modules including envelope management, reusable templates, recipient routing, authentication options, and audit trail reporting to support external signing workflows and internal document lifecycle processes. Operational scope centers on website-driven interactions with external stakeholders, while governance emphasizes template control, access permissions, and secure audit logging to maintain signature integrity and records retention.
|
Amicus Therapeutics CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
CRM | CRM |
|
2016 | 2016 |
|
|
|
|
|
Customer Experience | CRM |
|
2018 | 2018 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2016 | 2016 |
|
|
|
|
|
Marketing Automation | CRM |
|
2018 | 2018 |
|
Amicus Therapeutics PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Transactional Email | PaaS |
|
2019 | 2019 |
|
Amicus Therapeutics IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2013 | 2013 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2017 | 2017 |
|
Amicus Therapeutics CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at Amicus Therapeutics
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Chief Legal Officer and Corporate Secretary | CXO | Legal | |
|
|
|
Manager of Quality and Compliance | Manager | Finance | |
|
|
|
Director, Global Compliance Auditing and Monitoring | Director | Finance | |
|
|
|
Director, Human Resources | Director | HR | |
|
Apps Being Evaluated by Amicus Therapeutics Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Amicus Therapeutics IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Amicus Therapeutics digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Amicus Therapeutics Technographics
Amicus Therapeutics is a Life Sciences organization based in United States,
with around 500 employees and annual revenues of $306.0 million.
Amicus Therapeutics operates a diverse technology stack with applications such as
Sterling Background Check, Veeva CRM Events Management and DocuSign eSignature,
covering areas like BackGround Screening, Event Management and Digital Signing.
Amicus Therapeutics has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Sterling Talent Solutions, Veeva Systems and Docusign.
Amicus Therapeutics recently adopted applications including
DocuSign eSignature in 2021, Okta Identity Cloud in 2021 and Amazon SES in 2019,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Amicus Therapeutics’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Amicus Therapeutics’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Amicus Therapeutics technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.